We are live on ! Find out more
ACM

Azimuth Capital Management Portfolio holdings

AUM $2.34B
1-Year Est. Return 16.67%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+16.67%
3 Year Est. Return
+80.26%
5 Year Est. Return
+136.66%
10 Year Est. Return
AUM
$897M
AUM Growth
+$68.9M
Cap. Flow
+$76M
Cap. Flow %
8.47%
Top 10 Hldgs %
18.78%
Holding
287
New
17
Increased
155
Reduced
70
Closed
8

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$3.78M
2
PRU icon
Prudential Financial
PRU
+$2.71M
3
MRK icon
Merck
MRK
+$2.18M
4
PRGO icon
Perrigo
PRGO
+$2.13M
5
CLB icon
Core Laboratories
CLB
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 20.61%
2 Technology 14.15%
3 Industrials 12.57%
4 Consumer Staples 10.19%
5 Energy 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.82T
$7.64M 0.85%
1,060,700
-3,300
-0.3% -$22.1K
MCK icon
27
McKesson
MCK
$98.5B
$7.63M 0.85%
40,962
+1,011
+3% +$180K
BMY icon
28
Bristol-Myers Squibb
BMY
$127B
$7.61M 0.85%
156,912
-270
-0.2% -$13.3K
DIS icon
29
Walt Disney
DIS
$165B
$7.54M 0.84%
87,993
-2,160
-2% -$176K
SYK icon
30
Stryker
SYK
$127B
$7.47M 0.83%
88,649
+5,314
+6% +$434K
CL icon
31
Colgate-Palmolive
CL
$72.6B
$7.43M 0.83%
108,978
+695
+0.6% +$46.6K
CVX icon
32
Chevron
CVX
$388B
$7.29M 0.81%
55,854
+5,228
+10% +$650K
JPM icon
33
JPMorgan Chase
JPM
$939B
$7.18M 0.8%
124,604
-67,204
-35% -$3.78M
RMD icon
34
ResMed
RMD
$28.3B
$7.18M 0.8%
141,750
-2,200
-2% -$109K
ADP icon
35
Automatic Data Processing
ADP
$100B
$7.16M 0.8%
102,878
-3,474
-3% -$237K
BLK icon
36
Blackrock
BLK
$164B
$7.02M 0.78%
21,956
+681
+3% +$209K
GD icon
37
General Dynamics
GD
$105B
$6.97M 0.78%
59,773
-92
-0.2% -$10.5K
KRFT
38
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$6.85M 0.76%
114,189
+4,546
+4% +$263K
TSS
39
DELISTED
Total System Services, Inc.
TSS
$6.56M 0.73%
208,713
+101
+0% +$3.1K
LLY icon
40
Eli Lilly
LLY
$1.07T
$6.53M 0.73%
104,966
+2,442
+2% +$146K
KO icon
41
Coca-Cola
KO
$354B
$6.38M 0.71%
150,529
-6,415
-4% -$260K
GILD icon
42
Gilead Sciences
GILD
$161B
$6.37M 0.71%
76,834
-9,017
-11% -$702K
KMB icon
43
Kimberly-Clark
KMB
$36.4B
$6.18M 0.69%
57,960
+904
+2% +$96.1K
QCOM icon
44
Qualcomm
QCOM
$176B
$6.1M 0.68%
77,076
+20,201
+36% +$1.61M
EMR icon
45
Emerson Electric
EMR
$82.9B
$6.1M 0.68%
91,882
-747
-0.8% -$50.2K
BIIB icon
46
Biogen
BIIB
$29.9B
$6.04M 0.67%
19,142
+1
+0% +$301
FFIV icon
47
F5
FFIV
$22.1B
$5.97M 0.67%
53,561
+35,251
+193% +$3.79M
DD icon
48
DuPont de Nemours
DD
$18.6B
$5.95M 0.66%
45,684
+327
+0.7% +$41.7K
MDLZ icon
49
Mondelez International
MDLZ
$77.7B
$5.88M 0.66%
156,394
-5,952
-4% -$218K
HD icon
50
Home Depot
HD
$332B
$5.87M 0.65%
72,551
+1,223
+2% +$96.5K

Similar funds

Azimuth Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Azimuth Capital Management held 287 positions worth $897M, up 8.3% from $829M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Azimuth Capital Management deployed $76M of net new capital in Q2 2014, opening 17 new positions and adding to 155 existing holdings. Its largest new stake was KINDER MORGAN MANAGEMENT LLC: 545,153 shares worth $0.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $3.78M trimmed.

  • Azimuth Capital Management's largest Q2 2014 buy was KINDER MORGAN MANAGEMENT LLC: 545,153 shares worth $0.
  • Azimuth Capital Management added most to Wells Fargo in Q2 2014, an estimated $5.07M increase.
  • Azimuth Capital Management's biggest Q2 2014 reduction was JPMorgan Chase, cutting an estimated $3.78M.
  • Azimuth Capital Management fully exited Prudential Financial in Q2 2014, selling an estimated $2.71M.
  • Azimuth Capital Management's ten largest holdings make up 19% of its $897M portfolio in Q2 2014.
  • Azimuth Capital Management opened 17 new positions and closed 8 in Q2 2014.
  • Azimuth Capital Management's portfolio value rose 8.3% quarter-over-quarter to $897M.

Based on Azimuth Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.